Photo from wikipedia
Abstract There was no structured method for safely transition from parenteral prostanoids to oral medication. We enrolled 37 idiopathic/hereditary pulmonary arterial hypertension patients receiving triple combination therapy including parenteral prostanoids… Click to show full abstract
Abstract There was no structured method for safely transition from parenteral prostanoids to oral medication. We enrolled 37 idiopathic/hereditary pulmonary arterial hypertension patients receiving triple combination therapy including parenteral prostanoids into structured transition program to oral selexipag. Four (10.8%) patients successfully transitioned under the protocol, and all of them presented long‐term safety.
Keywords:
long term;
arterial hypertension;
term safety;
pulmonary arterial;
parenteral prostanoids;
structured transition
Journal Title: Pulmonary Circulation
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Pulmonary Circulation
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!